Integrative physiology of orexins and orexin receptors

CNS and Neurological Disorders - Drug Targets

Volumn 8, Issue 4, 2009, Pages 281-295

  Mieda, Michihiro ^a   Sakurai, Takeshi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Emotion; Energy homeostasis; Hypothalamus; Narcolepsy cataplexy; Orexin; Orphan GPCR; Reward; Sleep wake

Indexed keywords

OREXIN; OREXIN 1 RECEPTOR; OREXIN 2 RECEPTOR; G PROTEIN COUPLED RECEPTOR; NEUROPEPTIDE; NEUROPEPTIDE RECEPTOR; OREXIN RECEPTORS; OREXINS; SIGNAL PEPTIDE;

CATAPLEXY; CIRCADIAN RHYTHM; DRINKING BEHAVIOR; EMOTION; ENERGY BALANCE; FEEDING BEHAVIOR; HUMAN; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NARCOLEPSY; NEUROENDOCRINOLOGY; NEUROMODULATION; NEUROPHYSIOLOGY; NONHUMAN; NONREM SLEEP; REM SLEEP; REVIEW; REWARD; SLEEP; SLEEP WAKING CYCLE; WAKEFULNESS; ANIMAL; ANIMAL BEHAVIOR; BIOLOGICAL MODEL; BRAIN; ENERGY METABOLISM; HOMEOSTASIS; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CATAPLEXY; ENERGY METABOLISM; FEEDING BEHAVIOR; HOMEOSTASIS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MODELS, NEUROLOGICAL; NARCOLEPSY; NEUROPEPTIDES; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE; WAKEFULNESS;

EID: 70350439281     PISSN: 18715273     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152709788921663     Document Type: Review

References (131)

1. Sakurai, T.; Amemiya, A.; Ishii, M.; Matsuzaki, I.; Chemelli, R.M.; Tanaka, H.; Williams, S.C.; Richardson, J.A.; Kozlowski, G.P.; Wilson, S.; Arch, J.R.; Buckingham, R.E.; Haynes, A.C.; Carr, S.A.; Annan, R.S.; McNulty, D.E.; Liu, W.S.; Terrett, J.A.; Elshourbagy, N.A.; Bergsma, D.J.; Yanagisawa, M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell, 1998, 92, 573-585.
2. de Lecea, L.; Kilduff, T.S.; Peyron, C.; Gao, X.; Foye, P.E.; Danielson, P.E.; Fukuhara, C.; Battenberg, E.L.; Gautvik, V.T.; Bartlett, F.S., 2nd; Frankel, W.N.; van den Pol, A.N.; Bloom, F.E.; Gautvik, K.M.; Sutcliffe, J.G. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. USA, 1998, 95, 322-327.
3. Zhu, Y.; Miwa, Y.; Yamanaka, A.; Yada, T.; Shibahara, M.; Abe, Y.; Sakurai, T.; Goto, K. Orexin receptor type-1 couples exclusively to pertussis toxin-insensitive G-proteins, while orexin receptor type-2 couples to both pertussis toxin-sensitive and - insensitive G-proteins. J. Pharmacol. Sci., 2003, 92, 259-266.
4. Nambu, T.; Sakurai, T.; Mizukami, K.; Hosoya, Y.; Yanagisawa, M.; Goto, K. Distribution of orexin neurons in the adult rat brain. Brain Res., 1999, 827, 243-260.
5. Peyron, C.; Tighe, D.K.; van den Pol, A.N.; de Lecea, L.; Heller, H.C.; Sutcliffe, J.G.; Kilduff, T.S. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci., 1998, 18, 9996-10015.
6. Date, Y.; Ueta, Y.; Yamashita, H.; Yamaguchi, H.; Matsukura, S.; Kangawa, K.; Sakurai, T.; Yanagisawa, M.; Nakazato, M. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc. Natl. Acad. Sci. USA, 1999, 96, 748-753.
7. van den Pol, A.N. Hypothalamic hypocretin (orexin): robust innervation of the spinal cord. J. Neurosci., 1999, 19, 3171-3182.
8. Trivedi, P.; Yu, H.; MacNeil, D.J.; Van der Ploeg, L.H.; Guan, X.M. Distribution of orexin receptor mRNA in the rat brain. FEBS Lett., 1998, 438, 71-75.
9. Lu, X.Y.; Bagnol, D.; Burke, S.; Akil, H.; Watson, S.J. Differential distribution and regulation of OX1 and OX2 orexin/hypocretin receptor messenger RNA in the brain upon fasting. Horm. Behav., 2000, 37, 335-344.
10. Marcus, J.N.; Aschkenasi, C.J.; Lee, C.E.; Chemelli, R.M.; Saper, C.B.; Yanagisawa, M.; Elmquist, J.K. Differential expression of orexin receptors 1 and 2 in the rat brain. J. Comp. Neurol., 2001, 435, 6-25.
11. Mignot, E. Genetic and familial aspects of narcolepsy. Neurology, 1998, 50, S16-S22.
12. Chemelli, R.M.; Willie, J.T.; Sinton, C.M.; Elmquist, J.K.; Scammell, T.; Lee, C.; Richardson, J.A.; Williams, S.C.; Xiong, Y.; Kisanuki, Y.; Fitch, T.E.; Nakazato, M.; Hammer, R.E.; Saper, C.B.; Yanagisawa, M. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell, 1999, 98, 437-451.
13. Lin, L.; Faraco, J.; Li, R.; Kadotani, H.; Rogers, W.; Lin, X.; Qiu, X.; de Jong, P.J.; Nishino, S.; Mignot, E. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell, 1999, 98, 365-376.
14. Mignot, E.; Lammers, G.J.; Ripley, B.; Okun, M.; Nevsimalova, S.; Overeem, S.; Vankova, J.; Black, J.; Harsh, J.; Bassetti, C.; Schrader, H.; Nishino, S. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch. Neurol., 2002, 59, 1553-1562.
15. Peyron, C.; Faraco, J.; Rogers, W.; Ripley, B.; Overeem, S.; Charnay, Y.; Nevsimalova, S.; Aldrich, M.; Reynolds, D.; Albin, R.; Li, R.; Hungs, M.; Pedrazzoli, M.; Padigaru, M.; Kucherlapati, M.; Fan, J.; Maki, R.; Lammers, G.J.; Bouras, C.; Kucherlapati, R.; Nishino, S.; Mignot, E. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat. Med., 2000, 6, 991-997.
16. Thannickal, T.C.; Moore, R.Y.; Nienhuis, R.; Ramanathan, L.; Gulyani, S.; Aldrich, M.; Cornford, M.; Siegel, J.M. Reduced number of hypocretin neurons in human narcolepsy. Neuron, 2000, 27, 469-474.
17. Crocker, A.; Espana, R.A.; Papadopoulou, M.; Saper, C.B.; Faraco, J.; Sakurai, T.; Honda, M.; Mignot, E.; Scammell, T.E. Concomitant loss of dynorphin, NARP, and orexin in narcolepsy. Neurology, 2005, 65, 1184-1188.
18. Kadotani, H.; Faraco, J.; Mignot, E. Genetic studies in the sleep disorder narcolepsy. Genome Res., 1998, 8, 427-434.
19. Willie, J.T.; Chemelli, R.M.; Sinton, C.M.; Tokita, S.; Williams, S.C.; Kisanuki, Y.Y.; Marcus, J.N.; Lee, C.; Elmquist, J.K.; Kohlmeier, K.A.; Leonard, C.S.; Richardson, J.A.; Hammer, R.E.; Yanagisawa, M. Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes. Neuron, 2003, 38, 715-730.
20. Willie, J.T.; Chemelli, R.M.; Sinton, C.M.; Yanagisawa, M. To eat or to sleep? Orexin in the regulation of feeding and wakefulness. Annu. Rev. Neurosci., 2001, 24, 429-458.
21. Hara, J.; Beuckmann, C.T.; Nambu, T.; Willie, J.T.; Chemelli, R.M.; Sinton, C.M.; Sugiyama, F.; Yagami, K.; Goto, K.; Yanagisawa, M.; Sakurai, T. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron, 2001, 30, 345-354.
22. Abrahamson, E.E.; Leak, R.K.; Moore, R.Y. The suprachiasmatic nucleus projects to posterior hypothalamic arousal systems. Neuroreport, 2001, 12, 435-440.
23. Chou, T.C.; Lee, C.E.; Lu, J.; Elmquist, J.K.; Hara, J.; Willie, J.T.; Beuckmann, C.T.; Chemelli, R.M.; Sakurai, T.; Yanagisawa, M.; Saper, C.B.; Scammell, T.E. Orexin (hypocretin) neurons contain dynorphin. J. Neurosci., 2001, 21, RC168.
24. Rosin, D.L.; Weston, M.C.; Sevigny, C.P.; Stornetta, R.L.; Guyenet, P.G. Hypothalamic orexin (hypocretin) neurons express vesicular glutamate transporters VGLUT1 or VGLUT2. J. Comp. Neurol., 2003, 465, 593-603.
25. American Academy of Sleep medicine, D.C.S.C. The International Classification of Sleep Disorders: Diagnostic and Coding Manual, 2005, (American Academy of Sleep Medicine).
26. Zeitzer, J.M.; Nishino, S.; Mignot, E. The neurobiology of hypocretins (orexins), narcolepsy and related therapeutic interventions. Trends Pharmacol. Sci., 2006, 27, 368-374.
27. Mieda, M.; Willie, J.T.; Hara, J.; Sinton, C.M.; Sakurai, T.; Yanagisawa, M. Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice. Proc. Natl. Acad. Sci. USA, 2004, 101, 4649-4654.
28. Fujiki, N.; Yoshida, Y.; Ripley, B.; Mignot, E.; Nishino, S. Effects of IV and ICV hypocretin-1 (orexin A) in hypocretin receptor-2 gene mutated narcoleptic dogs and IV hypocretin-1 replacement therapy in a hypocretin-ligand-deficient narcoleptic dog. Sleep, 2003, 26, 953-959.
29. Brisbare-Roch, C.; Dingemanse, J.; Koberstein, R.; Hoever, P.; Aissaoui, H.; Flores, S.; Mueller, C.; Nayler, O.; van Gerven, J.; de Haas, S.L.; Hess, P.; Qiu, C.; Buchmann, S.; Scherz, M.; Weller, T.; Fischli, W.; Clozel, M.; Jenck, F. Promotion of sleep by targeting the orexin system in rats, dogs and humans. Nat. Med., 2007, 13, 150-155.
30. Hishikawa, Y.; Shimizu, T. Physiology of REM sleep, cataplexy, and sleep paralysis. Adv. Neurol., 1995, 67, 245-271.
31. Saper, C.B.; Chou, T.C.; Scammell, T.E. The sleep switch: hypothalamic control of sleep and wakefulness. Trends Neurosci., 2001, 24, 726-731.
32. Horvath, T. L.; Peyron, C.; Diano, S.; Ivanov, A.; Aston-Jones, G.; Kilduff, T.S.; van Den Pol, A.N. Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system. J. Comp. Neurol., 1999, 415, 145-159.
33. Yamanaka, A.; Tsujino, N.; Funahashi, H.; Honda, K.; Guan, J.L.; Wang, Q.P.; Tominaga, M.; Goto, K.; Shioda, S.; Sakurai, T. Orexins activate histaminergic neurons via the orexin 2 receptor. Biochem. Biophys. Res. Commun., 2002, 290, 1237-1245.
34. Hagan, J.J.; Leslie, R.A.; Patel, S.; Evans, M.L.; Wattam, T.A.; Holmes, S.; Benham, C.D.; Taylor, S.G.; Routledge, C.; Hemmati, P.; Munton, R.P.; Ashmeade, T.E.; Shah, A.S.; Hatcher, J.P.; Hatcher, P.D.; Jones, D.N.; Smith, M.I.; Piper, D.C.; Hunter, A.J.; Porter, R.A.; Upton, N. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc. Natl. Acad. Sci. USA, 1999, 96, 10911-10916.
35. Adamantidis, A.R.; Zhang, F.; Aravanis, A.M.; Deisseroth, K.; de Lecea, L. Neural substrates of awakening probed with optogenetic control of hypocretin neurons. Nature, 2007, 450, 420-424.
36. Bourgin, P.; Huitron-Resendiz, S.; Spier, A.D.; Fabre, V.; Morte, B.; Criado, J.R.; Sutcliffe, J.G.; Henriksen, S.J.; de Lecea, L. Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons. J. Neurosci., 2000, 20, 7760-7765.
37. Huang, Z.L.; Qu, W.M.; Li, W.D.; Mochizuki, T.; Eguchi, N.; Watanabe, T.; Urade, Y.; Hayaishi, O. Arousal effect of orexin A depends on activation of the histaminergic system. Proc. Natl. Acad. Sci. USA, 2001, 98, 9965-9970.
38. Espana, R.A.; Baldo, B.A.; Kelley, A.E.; Berridge, C.W. Wake-promoting and sleep-suppressing actions of hypocretin (orexin): basal forebrain sites of action. Neuroscience, 2001, 106, 699-715.
39. Xi, M.C.; Morales, F.R.; Chase, M.H. Effects on sleep and wakefulness of the injection of hypocretin-1 (orexin-A) into the laterodorsal tegmental nucleus of the cat. Brain Res., 2001, 901, 259-264.
40. Methippara, M.M.; Alam, M.N.; Szymusiak, R.; McGinty, D. Effects of lateral preoptic area application of orexin-A on sleep-wakefulness. Neuroreport, 2000, 11, 3423-3426.
41. van den Pol, A.N.; Ghosh, P.K.; Liu, R.J.; Li, Y.; Aghajanian, G.K.; Gao, X.B. Hypocretin (orexin) enhances neuron activity and cell synchrony in developing mouse GFP-expressing locus coeruleus. J. Physiol., 2002, 541, 169-185.
42. Brown, R.E.; Sergeeva, O.; Eriksson, K.S.; Haas, H.L. Orexin A excites serotonergic neurons in the dorsal raphe nucleus of the rat. Neuropharmacology, 2001, 40, 457-459.
43. Liu, R.J.; van den Pol, A.N.; Aghajanian, G.K. Hypocretins (orexins) regulate serotonin neurons in the dorsal raphe nucleus by excitatory direct and inhibitory indirect actions. J. Neurosci., 2002, 22, 9453-9464.
44. Bayer, L.; Eggermann, E.; Serafin, M.; Saint-Mleux, B.; Machard, D.; Jones, B.; Muhlethaler, M. Orexins (hypocretins) directly excite tuberomammillary neurons. Eur. J. Neurosci., 2001, 14, 1571-1575.
45. Eriksson, K.S.; Sergeeva, O.; Brown, R.E.; Haas, H.L. Orexin/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus. J. Neurosci., 2001, 21, 9273-9279.
46. Eggermann, E.; Serafin, M.; Bayer, L.; Machard, D.; Saint-Mleux, B.; Jones, B.E.; Muhlethaler, M. Orexins/hypocretins excite basal forebrain cholinergic neurones. Neuroscience, 2001, 108, 177-181.
47. Burlet, S.; Tyler, C.J.; Leonard, C.S. Direct and indirect excitation of laterodorsal tegmental neurons by Hypocretin/Orexin peptides: implications for wakefulness and narcolepsy. J. Neurosci., 2002, 22, 2862-2872.
48. Takakusaki, K.; Takahashi, K.; Saitoh, K.; Harada, H.; Okumura, T.; Kayama, Y.; Koyama, Y. Orexinergic projections to the cat midbrain mediate alternation of emotional behavioural states from locomotion to cataplexy. J. Physiol., 2005, 568, 1003-1020.
49. Sakurai, T.; Nagata, R.; Yamanaka, A.; Kawamura, H.; Tsujino, N.; Muraki, Y.; Kageyama, H.; Kunita, S.; Takahashi, S.; Goto, K.; Koyama, Y.; Shioda, S.; Yanagisawa, M. Input of orexin/hypocretin neurons revealed by a genetically encoded tracer in mice. Neuron, 2005, 46, 297-308.
50. Yoshida, K.; McCormack, S.; Espana, R.A.; Crocker, A.; Scammell, T.E. Afferents to the orexin neurons of the rat brain. J. Comp. Neurol., 2006, 494, 845-861.
51. Li, Y.; Gao, X.B.; Sakurai, T.; van den Pol, A.N. Hypocretin/Orexin excites hypocretin neurons via a local glutamate neuron-A potential mechanism for orchestrating the hypothalamic arousal system. Neuron, 2002, 36, 1169-1181.
52. Yamanaka, A.; Beuckmann, C.T.; Willie, J.T.; Hara, J.; Tsujino, N.; Mieda, M.; Tominaga, M.; Yagami, K.; Sugiyama, F.; Goto, K.; Yanagisawa, M.; Sakurai, T. Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron, 2003, 38, 701-713.
53. Xie, X.; Crowder, T.L.; Yamanaka, A.; Morairty, S.R.; Lewinter, R.D.; Sakurai, T.; Kilduff, T.S. GABA(B) receptor-mediated modulation of hypocretin/orexin neurones in mouse hypothalamus. J. Physiol., 2006, 574, 399-414.
54. Yamanaka, A.; Muraki, Y.; Tsujino, N.; Goto, K.; Sakurai, T. Regulation of orexin neurons by the monoaminergic and cholinergic systems. Biochem. Biophys. Res. Commun., 2003, 303, 120-129.
55. Muraki, Y.; Yamanaka, A.; Tsujino, N.; Kilduff, T.S.; Goto, K.; Sakurai, T. Serotonergic regulation of the orexin/hypocretin neurons through the 5-HT1A receptor. J. Neurosci., 2004, 24, 7159-7166.
56. Yamanaka, A.; Muraki, Y.; Ichiki, K.; Tsujino, N.; Kilduff, T.S.; Goto, K.; Sakurai, T. Orexin neurons are directly and indirectly regulated by catecholamines in a complex manner. J. Neurophysiol., 2006, 96, 284-298.
57. Grivel, J.; Cvetkovic, V.; Bayer, L.; Machard, D.; Tobler, I.; Muhlethaler, M.; Serafin, M. The wake-promoting hypocretin/orexin neurons change their response to noradrenaline after sleep deprivation. J. Neurosci., 2005, 25, 4127-4130.
58. Matsuki, T.; Nomiyama, M.; Takahira, H.; Hirashima, N.; Kilduff, T.S.; Kunita, S.; Takahashi, S.; Yagami, K.; Bettler, B.; Yanagisawa, M.; Sakurai, T. Selective loss of GABAB receptors in orexin-producing neurons results in disrupted sleep/wakefulness architecture. Proc. Natl. Acad. Sci. USA, 2009, 106(11), 4459-64.
59. Horvath, T.L.; Gao, X.B. Input organization and plasticity of hypocretin neurons: possible clues to obesity's association with insomnia. Cell Metab., 2005, 1, 279-286.
60. Rao, Y.; Liu, Z.W.; Borok, E.; Rabenstein, R.L.; Shanabrough, M.; Lu, M.; Picciotto, M.R.; Horvath, T.L.; Gao, X.B. Prolonged wakefulness induces experience-dependent synaptic plasticity in mouse hypocretin/orexin neurons. J. Clin. Invest., 2007, 117, 4022-4033.
61. Estabrooke, I.V.; McCarthy, M.T.; Ko, E.; Chou, T.C.; Chemelli, R.M.; Yanagisawa, M.; Saper, C.B.; Scammell, T.E. Fos expression in orexin neurons varies with behavioral state. J. Neurosci., 2001, 21, 1656-1662.
62. Yoshida, Y.; Fujiki, N.; Nakajima, T.; Ripley, B.; Matsumura, H.; Yoneda, H.; Mignot, E.; Nishino, S. Fluctuation of extracellular hypocretin-1 (orexin A) levels in the rat in relation to the light-dark cycle and sleep-wake activities. Eur. J. Neurosci., 2001, 14, 1075-1081.
63. Mileykovskiy, B.Y.; Kiyashchenko, L.I.; Siegel, J.M. Behavioral correlates of activity in identified hypocretin/orexin neurons. Neuron, 2005, 46, 787-798.
64. Lee, M.G.; Hassani, O.K.; Jones, B.E. Discharge of identified orexin/hypocretin neurons across the sleep-waking cycle. J. Neurosci., 2005, 25, 6716-6720.
65. Takahashi, K.; Lin, J.S.; Sakai, K. Neuronal activity of orexin and non-orexin waking-active neurons during wake-sleep states in the mouse. Neuroscience, 2008, 153, 860-870.
66. Liu, Z.W.; Gao, X.B. Adenosine inhibits activity of hypocretin/orexin neurons by the A1 receptor in the lateral hypothalamus: a possible sleep-promoting effect. J. Neurophysiol., 2007, 97, 837-848.
67. Deadwyler, S.A.; Porrino, L.; Siegel, J.M.; Hampson, R.E. Systemic and nasal delivery of orexin-A (Hypocretin-1) reduces the effects of sleep deprivation on cognitive performance in nonhuman primates. J. Neurosci., 2007, 27, 14239-14247.
68. Lambe, E.K.; Olausson, P.; Horst, N.K.; Taylor, J.R.; Aghajanian, G.K. Hypocretin and nicotine excite the same thalamocortical synapses in prefrontal cortex: correlation with improved attention in rat. J. Neurosci., 2005, 25, 5225-5229.
69. Lambe, E.K.; Aghajanian, G.K. Hypocretin (orexin) induces calcium transients in single spines postsynaptic to identified thalamocortical boutons in prefrontal slice. Neuron, 2003, 40, 139-150.
70. Edwards, C.M.; Abusnana, S.; Sunter, D.; Murphy, K.G.; Ghatei, M.A.; Bloom, S.R. The effect of the orexins on food intake: comparison with neuropeptide Y, melanin-concentrating hormone and galanin. J. Endocrinol., 1999, 160, R7-R12.
71. Haynes, A.C.; Jackson, B.; Overend, P.; Buckingham, R.E.; Wilson, S.; Tadayyon, M.; Arch, J.R. Effects of single and chronic intracerebroventricular administration of the orexins on feeding in the rat. Peptides, 1999, 20, 1099-1105.
72. Ida, T.; Nakahara, K.; Katayama, T.; Murakami, N.; Nakazato, M. Effect of lateral cerebroventricular injection of the appetite-stimulating neuropeptide, orexin and neuropeptide Y, on the various behavioral activities of rats. Brain Res., 1999, 821, 526-529.
73. Yamanaka, A.; Sakurai, T.; Katsumoto, T.; Yanagisawa, M.; Goto, K. Chronic intracerebroventricular administration of orexin-A to rats increases food intake in daytime, but has no effect on body weight. Brain Res., 1999, 849, 248-252.
74. Haynes, A.C.; Jackson, B.; Chapman, H.; Tadayyon, M.; Johns, A.; Porter, R.A.; Arch, J.R. A selective orexin-1 receptor antagonist reduces food consumption in male and female rats. Regul. Pept., 2000, 96, 45-51.
75. Yamada, H.; Okumura, T.; Motomura, W.; Kobayashi, Y.; Kohgo, Y. Inhibition of food intake by central injection of anti-orexin antibody in fasted rats. Biochem. Biophys. Res. Commun., 2000, 267, 527-531.
76. Haynes, A.C.; Chapman, H.; Taylor, C.; Moore, G.B.; Cawthorne, M.A.; Tadayyon, M.; Clapham, J.C.; Arch, J.R. Anorectic, thermogenic and anti-obesity activity of a selective orexin-1 receptor antagonist in ob/ob mice. Regul. Pept., 2002, 104, 153-159.
77. Lammers, G.J.; Pijl, H.; Iestra, J.; Langius, J.A.; Buunk, G.; Meinders, A.E. Spontaneous food choice in narcolepsy. Sleep, 1996, 19, 75-76.
78. Schuld, A.; Hebebrand, J.; Geller, F.; Pollmacher, T. Increased body-mass index in patients with narcolepsy. Lancet, 2000, 355, 1274-1275.
79. Hara, J.; Yanagisawa, M.; Sakurai, T. Difference in obesity phenotype between orexin-knockout mice and orexin neuron-deficient mice with same genetic background and environmental conditions. Neurosci. Lett., 2005, 380, 239-242.
80. Broberger, C.; De Lecea, L.; Sutcliffe, J.G.; Hokfelt, T. Hypocretin/orexin- and melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: relationship to the neuropeptide Y and agouti gene-related protein systems. J. Comp. Neurol., 1998, 402, 460-474.
81. Elias, C.F.; Saper, C.B.; Maratos-Flier, E.; Tritos, N.A.; Lee, C.; Kelly, J.; Tatro, J.B.; Hoffman, G.E.; Ollmann, M.M.; Barsh, G.S.; Sakurai, T.; Yanagisawa, M.; Elmquist, J.K. Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area. J. Comp. Neurol., 1998, 402, 442-459.
82. Horvath, T.L.; Diano, S.; van den Pol, A.N. Synaptic interaction between hypocretin (orexin) and neuropeptide Y cells in the rodent and primate hypothalamus: a novel circuit implicated in metabolic and endocrine regulations. J. Neurosci., 1999, 19, 1072-1087.
83. Yamanaka, A.; Kunii, K.; Nambu, T.; Tsujino, N.; Sakai, A.; Matsuzaki, I.; Miwa, Y.; Goto, K.; Sakurai, T. Orexin-induced food intake involves neuropeptide Y pathway. Brain Res., 2000, 859, 404-409.
84. 2+ signaling in a reciprocal manner to leptin: orexigenic neuronal pathways in the mediobasal hypothalamus. Eur. J. Neurosci., 2004, 19, 1524-1534.
85. Thorpe, A.J.; Kotz, C.M. Orexin A in the nucleus accumbens stimulates feeding and locomotor activity. Brain Res., 2005, 1050, 156-162.
86. Baldo, B.A.; Gual-Bonilla, L.; Sijapati, K.; Daniel, R.A.; Landry, C.F.; Kelley, A.E. Activation of a subpopulation of orexin/hypocretin-containing hypothalamic neurons by GABAA receptor-mediated inhibition of the nucleus accumbens shell, but not by exposure to a novel environment. Eur. J. Neurosci., 2004, 19, 376-386.
87. Lubkin, M.; Stricker-Krongrad, A. Independent feeding and metabolic actions of orexins in mice. Biochem. Biophys. Res. Commun., 1998, 253, 241-245.
88. Spiegelman, B.M.; Flier, J.S. Obesity and the regulation of energy balance. Cell, 2001, 104, 531-543.
89. Shirasaka, T.; Nakazato, M.; Matsukura, S.; Takasaki, M.; Kannan, H. Sympathetic and cardiovascular actions of orexins in conscious rats. Am. J. Physiol., 1999, 277, R1780-R1785.
90. Kayaba, Y.; Nakamura, A.; Kasuya, Y.; Ohuchi, T.; Yanagisawa, M.; Komuro, I.; Fukuda, Y.; Kuwaki, T. Attenuated defense response and low basal blood pressure in orexin knockout mice. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2003, 285, R581-R593.
91. Zhang, W.; Sakurai, T.; Fukuda, Y.; Kuwaki, T. Orexin neuron-mediated skeletal muscle vasodilation and shift of baroreflex during defense response in mice. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2006, 290, R1654-R1663.
92. Moriguchi, T.; Sakurai, T.; Nambu, T.; Yanagisawa, M.; Goto, K. Neurons containing orexin in the lateral hypothalamic area of the adult rat brain are activated by insulin-induced acute hypoglycemia. Neurosci. Lett., 1999, 264, 101-104.
93. Burdakov, D.; Gerasimenko, O.; Verkhratsky, A. Physiological changes in glucose differentially modulate the excitability of hypothalamic melanin-concentrating hormone and orexin neurons in situ. J. Neurosci., 2005, 25, 2429-2433.
94. Burdakov, D.; Jensen, L.T.; Alexopoulos, H.; Williams, R.H.; Fearon, I.M.; O'Kelly, I.; Gerasimenko, O.; Fugger, L.; Verkhratsky, A. Tandem-pore K+ channels mediate inhibition of orexin neurons by glucose. Neuron, 2006, 50, 711-722.
95. Challet, E.; Pevet, P.; Malan, A. Effect of prolonged fasting and subsequent refeeding on free-running rhythms of temperature and locomotor activity in rats. Behav. Brain Res., 1997, 84, 275-284.
96. Itoh, T.; Murai, S.; Nagahama, H.; Miyate, H.; Abe, E.; Fujiwara, H.; Saito, Y. Effects of 24-hr fasting on methamphetamine- and apomorphine-induced locomotor activities, and on monoamine metabolism in mouse corpus striatum and nucleus accumbens. Pharmacol. Biochem. Behav., 1990, 35, 391-396.
97. Mieda, M.; Williams, S.C.; Sinton, C.M.; Richardson, J.A.; Sakurai, T.; Yanagisawa, M. Orexin neurons function in an efferent pathway of a food-entrainable circadian oscillator in eliciting food-anticipatory activity and wakefulness. J. Neurosci., 2004, 24, 10493-10501.
98. Akiyama, M.; Yuasa, T.; Hayasaka, N.; Horikawa, K.; Sakurai, T.; Shibata, S. Reduced food anticipatory activity in genetically orexin (hypocretin) neuron-ablated mice. Eur. J. Neurosci., 2004, 20, 3054-3062.
99. Kunii, K.; Yamanaka, A.; Nambu, T.; Matsuzaki, I.; Goto, K.; Sakurai, T. Orexins/hypocretins regulate drinking behaviour. Brain Res., 1999, 842, 256-261.
100. Tsunematsu, T.; Fu, L.Y.; Yamanaka, A.; Ichiki, K.; Tanoue, A.; Sakurai, T.; van den Pol, A.N. Vasopressin increases locomotion through a V1a receptor in orexin/hypocretin neurons: implications for water homeostasis. J. Neurosci., 2008, 28, 228-238.
101. Tsujino, N.; Yamanaka, A.; Ichiki, K.; Muraki, Y.; Kilduff, T.S.; Yagami, K.; Takahashi, S.; Goto, K.; Sakurai, T. Cholecystokinin activates orexin/hypocretin neurons through the cholecystokinin A receptor. J. Neurosci., 2005, 25, 7459-7469.
102. Fadel, J.; Deutch, A.Y. Anatomical substrates of orexin-dopamine interactions: lateral hypothalamic projections to the ventral tegmental area. Neuroscience, 2002, 111, 379-387.
103. Nakamura, T.; Uramura, K.; Nambu, T.; Yada, T.; Goto, K.; Yanagisawa, M.; Sakurai, T. Orexin-induced hyperlocomotion and stereotypy are mediated by the dopaminergic system. Brain Res., 2000, 873, 181-187.
104. Korotkova, T.M.; Sergeeva, O.A.; Eriksson, K.S.; Haas, H.L.; Brown, R.E. Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins. J. Neurosci., 2003, 23, 7-11.
105. Li, Y.; van den Pol, A.N. Direct and indirect inhibition by catecholamines of hypocretin/orexin neurons. J. Neurosci., 2005, 25, 173-183.
106. Harris, G.C.; Wimmer, M.; Aston-Jones, G. A role for lateral hypothalamic orexin neurons in reward seeking. Nature, 2005, 437, 556-559.
107. Narita, M.; Nagumo, Y.; Hashimoto, S.; Khotib, J.; Miyatake, M.; Sakurai, T.; Yanagisawa, M.; Nakamachi, T.; Shioda, S.; Suzuki, T. Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine. J. Neurosci., 2006, 26, 398-405.
108. Borgland, S.L.; Taha, S.A.; Sarti, F.; Fields, H.L.; Bonci, A. Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron, 2006, 49, 589-601.
109. Muschamp, J.W.; Dominguez, J.M.; Sato, S.M.; Shen, R.Y.; Hull, E.M. A role for hypocretin (orexin) in male sexual behavior. J. Neurosci., 2007, 27, 2837-2845.
110. Boutrel, B.; Kenny, P.J.; Specio, S.E.; Martin-Fardon, R.; Markou, A.; Koob, G.F.; de Lecea, L. Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc. Natl. Acad. Sci. USA, 2005, 102, 19168-19173.
111. Georgescu, D.; Zachariou, V.; Barrot, M.; Mieda, M.; Willie, J.T.; Eisch, A.J.; Yanagisawa, M.; Nestler, E.J.; DiLeone, R.J. Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal. J. Neurosci., 2003, 23, 3106-3111.
112. Guilleminault, C.; Carskadon, M.; Dement, W.C. On the treatment of rapid eye movement narcolepsy. Arch. Neurol., 1974, 30, 90-93.
113. Jansen, A.S.; Nguyen, X.V.; Karpitskiy, V.; Mettenleiter, T.C.; Loewy, A.D. Central command neurons of the sympathetic nervous system: basis of the fight-or-flight response. Science, 1995, 270, 644-646.
114. Geerling, J.C.; Mettenleiter, T.C.; Loewy, A.D. Orexin neurons project to diverse sympathetic outflow systems. Neuroscience, 2003, 122, 541-550.
115. Kuru, M.; Ueta, Y.; Serino, R.; Nakazato, M.; Yamamoto, Y.; Shibuya, I.; Yamashita, H. Centrally administered orexin/hypocretin activates HPA axis in rats. Neuroreport, 2000, 11, 1977-1980.
116. Sakamoto, F.; Yamada, S.; Ueta, Y. Centrally administered orexin-A activates corticotropin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus and central amygdaloid nucleus of rats: possible involvement of central orexins on stress-activated central CRF neurons. Regul. Pept., 2004, 118, 183-191.
117. Winsky-Sommerer, R.; Yamanaka, A.; Diano, S.; Borok, E.; Roberts, A.J.; Sakurai, T.; Kilduff, T.S.; Horvath, T.L.; de Lecea, L. Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response. J. Neurosci., 2004, 24, 11439-11448.
118. Siegel, J.M.; Boehmer, L.N. Narcolepsy and the hypocretin systemwhere motion meets emotion. Nat. Clin. Pract. Neurol., 2006, 2, 548-556.
119. Guilleminault, C.; Heinzer, R.; Mignot, E.; Black, J. Investigations into the neurologic basis of narcolepsy. Neurology, 1998, 50, S8-S15.
120. Guilleminault, C.; Gelb, M. Clinical aspects and features of cataplexy. Adv. Neurol., 1995, 67, 65-77.
121. Berthoud, H.R. Mind versus metabolism in the control of food intake and energy balance. Physiol. Behav., 2004, 81, 781-793.
122. Hervieu, G.J.; Cluderay, J.E.; Harrison, D.C.; Roberts, J.C.; Leslie, R.A. Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord. Neuroscience, 2001, 103, 777-797.
123. Bingham, S.; Davey, P.T.; Babbs, A.J.; Irving, E.A.; Sammons, M.J.; Wyles, M.; Jeffrey, P.; Cutler, L.; Riba, I.; Johns, A.; Porter, R.A.; Upton, N.; Hunter, A.J.; Parsons, A.A. Orexin-A, an hypothalamic peptide with analgesic properties. Pain, 2001, 92, 81-90.
124. Yamamoto, T.; Nozaki-Taguchi, N.; Chiba, T. Analgesic effect of intrathecally administered orexin-A in the rat formalin test and in the rat hot plate test. Br. J. Pharmacol., 2002, 137, 170-176.
125. Xie, X.; Wisor, J.P.; Hara, J.; Crowder, T.L.; LeWinter, R.; Khroyan, T.V.; Yamanaka, A.; Diano, S.; Horvath, T.L.; Sakurai, T.; Toll, L.; Kilduff, T.S. Hypocretin/orexin and nociceptin/orphanin FQ coordinately regulate analgesia in a mouse model of stress-induced analgesia. J. Clin. Invest., 2008, 118, 2471-2481.
126. Leak, R.K.; Moore, R.Y. Topographic organization of suprachiasmatic nucleus projection neurons. J. Comp. Neurol., 2001, 433, 312-334.
127. Hastings, M.H.; Reddy, A.B.; Maywood, E.S. A clockwork web: circadian timing in brain and periphery, in health and disease. Nat. Rev. Neurosci., 2003, 4, 649-661.
128. Stephan, F.K. The "other" circadian system: food as a Zeitgeber. J. Biol. Rhythms, 2002, 17, 284-292.
129. Takahashi, K.; Koyama, Y.; Kayama, Y.; Yamamoto, M. Effects of orexin on the laterodorsal tegmental neurones. Psychiatry Clin. Neurosci., 2002, 56, 335-336.
130. Martin, J.H. Neuroanatomy: Text and Atlas, 2nd ed.; Appleton & Lange: Stamford, Connecticut, 2001.
131. Sakurai, T. The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat. Rev. Neurosci., 2007, 8, 171-181.